Skip to main content
Squarex Pharmaceutical Corporation (SQRX)
Squarex Pharmaceutical was planning to go public, but the IPO was withdrawn on May 19, 2023.
Stock Price: Pending
IPO price not available yet

Squarex Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
0.250.22
Research & Development
0.060.15
Operating Expenses
0.310.37
Operating Income
-0.31-0.37
Interest Expense / Income
0.060.02
Other Expense / Income
-0.28
Pretax Income
-0.36-0.68
Net Income
-0.36-0.68
Free Cash Flow
-0.18-0.28
EBITDA
-0.31-0.65
Depreciation & Amortization
-0
EBIT
-0.31-0.66
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).